Egypt Pharmaceuticals and Healthcare Report Q3 2015

Date: November 30, -0001
Pages: 135
Price:
US$ 1,295.00
Publisher: BMI RESEARCH
Report type: Strategic Report
Delivery: Download
ID: E868351A17DEN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: The positive outlook for Egypt's pharmaceutical market has been reinforced, with access to medicines increasing through enhancing health insurance uptake and a greater interest among foreign pharmaceutical companies. This represents an impressive turnaround, given the region's political instability in recent years.

Headline Expenditure Projections
  • Pharmaceuticals: EGP23.03bn (USD3.25bn) in 2014 to EGP25.48bn (USD3.36bn) in 2015; +10.7% in local currency terms and 3.5% in US dollar terms. Forecast upgraded from Q215 following availability of new historic trade data.
  • Healthcare: EGP98.34bn (USD13.88bn) in 2014 to EGP107.69bn (USD14.21bn) in 2015; +9.5% in local currency terms and 2.4% in US dollar terms. Forecast broadly in line with Q215.
BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Egypt 2011-2019)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2011-2019)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2011-2019)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2011-2019)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Egypt 2011-2019)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Egypt 2013-2019)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Egypt 2013-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Macroeconomic Forecast
Expenditure Breakdown
  Table: GDP By Expenditure (Egypt 2012-2019)
Industry Risk Reward Indices
Middle East And Africa Risk/Reward Index
Egypt Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Communicable Diseases
Non-Communicable Disease
Healthcare Sector
Private Healthcare Sector
Healthcare Financing
Healthcare Insurance
  Table: Healthcare Resources (Egypt 2009-2014)
  Table: Healthcare Personnel (Egypt 2009-2014)
  Table: Healthcare Activity (Egypt 2009-2014)
Research & Development
Clinical Trials
Regulatory Development
Medicines Registration
Regional Harmonisation
Counterfeit Medicines
Intellectual Property
Pricing Regime
Reimbursement Regime
Watch List Status
Competitive Landscape
Pharmaceutical Industry
  Table: HOLDIPHARMA's Joint Ventures, 2012
Domestic Pharmaceuticals Sector
  Table: HOLDIPHARMA's Affiliated Companies, 2012
  Table: HOLDIPHARMA's Financial Indicators, FY 2006/2007-FY2010/2011 (EGPmn)
  Table: HOLDIPHARMA's Net Operating Revenue by Affiliate, FY 2010/2011 (EGPmn)
  Table: Wholly Or Partially Owned Egyptian Pharmaceutical And Medical Device Companies By Parent Group
Foreign Pharmaceuticals Sector
Recent Industry Developments
Pharmaceutical Wholesale
Pharmaceutical Retail
Herbal And OTC Medicine
Company Profile
Egyptian International Pharmaceutical Industries Co (EIPICO)
South Egyptian Drug Industries (SEDICO)
Medical Union Pharmaceuticals (MUP)
Amoun Pharmaceutical Company (APC)
VACSERA
Misr Pharmaceuticals
GlaxoSmithKline
Sanofi
Pfizer
Novartis
Merck
AstraZeneca
Demographic Forecast
Demographic Outlook
  Table: Population Headline Indicators (Egypt 1990-2025)
  Table: Key Population Ratios (Egypt 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Egypt 1990-2025)
  Table: Population By Age Group (Egypt 1990-2025)
  Table: Population By Age Group % (Egypt 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Egypt Pharmaceuticals and Healthcare Report Q1 2015 US$ 1,295.00 Jan, 2015 · 127 pages
Egypt Pharmaceuticals and Healthcare Report Q2 2015 US$ 1,295.00 Apr, 2015 · 131 pages
Algeria Pharmaceuticals and Healthcare Report Q2 2015 US$ 1,295.00 Feb, 2015 · 99 pages
Belgium Pharmaceuticals and Healthcare Report Q4 2014 US$ 1,295.00 Sep, 2014 · 123 pages

Ask Your Question

Egypt Pharmaceuticals and Healthcare Report Q3 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: